The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Neutrophil-mediated innate immune resistance to mycobacteria
Open accessAbstract
Neutrophils contain antimicrobial peptides with antituberculous activity, but their contribution to immune resistance to tuberculosis (TB) infection has not been previously investigated to our knowledge. We determined differential white cell counts in peripheral blood of 189 adults who had come into contact with patients diagnosed with active TB in London, United Kingdom, and evaluated them for evidence of TB infection and capacity to restrict mycobacterial growth in whole-blood assays. Risk of TB infection was inversely and independently associated with peripheral blood neutrophil count in contacts of patients diagnosed with pulmonary TB. The ability of whole blood to restrict growth of Mycobacterium bovis bacille Calmette Guérin and Mycobacterium tuberculosis was impaired 7.3- and 3.1-fold, respectively, by neutrophil depletion. In microbiological media, human neutrophil peptides (HNPs) 1-3 killed M. tuberculosis. The neutrophil peptides cathelicidin LL-37 and lipocalin 2 restricted growth of the organism, the latter in an iron-dependent manner. Black African participants had lower neutrophil counts and lower circulating concentrations of HNP1-3 and lipocalin 2 than south Asian and white participants. Neutrophils contribute substantially to innate resistance to TB infection, an activity associated with their antimicrobial peptides. Elucidation of the regulation of neutrophil antimicrobial peptides could facilitate prevention and treatment of TB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, Lcn2−/− mice are more susceptible to mycobacterial infections (214), which might be different from the iron-sequestrating role of Lcn2 (215) but rather due to its function as efficient chemoattractant for neutrophils to sites of infection (216–218).”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [215]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression
Wang, T. T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J. L., Tavera-Mendoza, L. E., Lin, R., Hanrahan, J. W., Mader, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.2909 · Cited by 1,661
Goetz, D. H., Holmes, M. A., Borregaard, N., Bluhm, M. E., Raymond, K. N., & Strong, R. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00708-6 · Cited by 1,355
Global epidemiology of tuberculosis
Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68384-0 · Cited by 717
Rodríguez, G. M., Voskuil, M. I., Gold, B., Schoolnik, G. K., & Smith, I. (2002) · Infection and Immunity · doi:10.1128/iai.70.7.3371-3381.2002 · Cited by 493
Martineau, A. R., Wilkinson, K. A., Newton, S. M., Floto, R. A., Norman, A. W., Skolimowska, K., Davidson, R. N., Sørensen, O. E., Kampmann, B., Griffiths, C. J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7190 · Cited by 410
Self-citationRacial Differences in Susceptibility to Infection byMycobacterium tuberculosis
Stead, W. W., Senner, J. W., Reddick, W. T., & Lofgren, J. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220702 · Cited by 406
Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000
Joint Tuberculosis Committee of the British Thoracic Society (2000) · Thorax · doi:10.1136/thorax.55.11.887 · Cited by 367
Iron, mycobacteria and tuberculosis
Ratledge, C. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.08.012 · Cited by 344
Research works printed but not linked: 2
- Fu, 2003, Int. J. Tuberc. Lung Dis., 7, 1027
- Garrey, 1935, Phys. Rev., 15, 597
Cited by
Sorted by citations
Cell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,194
Macrophage defense mechanisms against intracellular bacteria
Weiss, G., & Schaible, U. E. (2015) · Immunological Reviews · doi:10.1111/imr.12266 · Cited by 989
Lawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 804
Diverse novel functions of neutrophils in immunity, inflammation, and beyond
Mócsai, A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122220 · Cited by 706
Innate immunity in tuberculosis: host defense vs pathogen evasion
Liu, C. H., Liu, H., & Ge, B. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.88 · Cited by 535
The X chromosome and sex-specific effects in infectious disease susceptibility
Schurz, H., Salie, M., Tromp, G., Hoal, E. G., Kinnear, C. J., & Möller, M. (2019) · Human Genomics · doi:10.1186/s40246-018-0185-z · Cited by 419
Hodgson, K., Morris, J. L., Bridson, T. L., Govan, B., Rush, C. M., & Ketheesan, N. (2014) · Immunology · doi:10.1111/imm.12394 · Cited by 375
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Lenaerts, A. J. M., Barry, C. E., & Dartois, V. A. (2015) · Immunological Reviews · doi:10.1111/imr.12252 · Cited by 371
Dynamic balance of pro‐ and anti‐inflammatory signals controls disease and limits pathology
Cicchese, J. M., Evans, S., Hult, C., Joslyn, L. R., Wessler, T., Millar, J. A., Marino, S., Cilfone, N. A., Mattila, J. T., Linderman, J. J., et al. (2018) · Immunological Reviews · doi:10.1111/imr.12671 · Cited by 344
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 332
Neutrophils in tuberculosis: friend or foe?
Lowe, D. M., Redford, P. S., Wilkinson, R. J., O’Garra, A., & Martineau, A. R. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.10.003 · Cited by 312
Self-citationBiological Differences Between the Sexes and Susceptibility to Tuberculosis
Nhamoyebonde, S., & Leslie, A. J. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu147 · Cited by 314
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 337
Yang, C.-T., Cambier, C. J., Davis, J. M., Hall, C. J., Crosier, P. S., & Ramakrishnan, L. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.07.009 · Cited by 293
Homeostatic Regulation of Blood Neutrophil Counts
von Vietinghoff, S., & Ley, K. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5183 · Cited by 304
Iron metabolism and the innate immune response to infection
Johnson, E. E., & Wessling-Resnick, M. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.001 · Cited by 253
“[25].”
The balance between protective and pathogenic immune responses in the TB-infected lung
Orme, I. M., Robinson, R., & Cooper, A. M. (2014) · Nature Immunology · doi:10.1038/ni.3048 · Cited by 295
Rivas-Santiago, B. T., Hernández‐Pando, R., Carranza, C., Juárez, E., Contreras, J. L., Aguilar‐León, D., Torres, M., & Sada, E. (2007) · Infection and Immunity · doi:10.1128/iai.01218-07 · Cited by 254
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine
Hansen, S. G., Zak, D. E., Xu, G., Ford, J. C., Marshall, E. E., Malouli, D., Gilbride, R. M., Hughes, C. M., Ventura, A. B., Ainslie, E., et al. (2018) · Nature Medicine · doi:10.1038/nm.4473 · Cited by 249
Innate immunity in tuberculosis: myths and truth
Korbel, D. S., Schneider, B. E., & Schaible, U. E. (2008) · Microbes and Infection · doi:10.1016/j.micinf.2008.07.039 · Cited by 242
Blomgran, R., & Ernst, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100001 · Cited by 238
Nouailles, G., Dorhoi, A., Koch, M., Zerrahn, J., Weiner, J. M., Fae, K. C., Arrey, F., Kuhlmann, S., Bandermann, S., Löwe, D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72030 · Cited by 229
Eliminating latent tuberculosis
Young, D. B., Gideon, H. P., & Wilkinson, R. J. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2009.02.005 · Cited by 221
Self-citationLipocalin 2 Is Required for Pulmonary Host Defense against Klebsiella Infection
Chan, Y. R., Liu, J. S., Pociask, D. A., Zheng, M., Mietzner, T. A., Berger, T., Mak, T. W., Clifton, M. C., Strong, R. K., Ray, P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803282 · Cited by 219
Verway, M. J., Bouttier, M., Wang, T. T., Carrier, M., Calderon, M. R., An, B., Devemy, E., McIntosh, F. A., Divangahi, M., Behr, M. A., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003407 · Cited by 222
Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
Kaufmann, S. H. E., Lange, C. G., Rao, M., Balaji, K. N., Lotze, M. T., Schito, M. L., Zumla, A. I., & Maeurer, M. J. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70033-5 · Cited by 219
The immunology of tuberculosis: From bench to bedside
Dheda, K. U. J., Schwander, S., Zhu, B., van Zyl-Smit, R. N., & Zhang, Y. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01739.x · Cited by 212
Martineau, A. R., Nhamoyebonde, S., Oni, T., Rangaka, M. X., Marais, S., Bangani, N., Tsekela, R., Bashe, L., Azevedo, V. D., Caldwell, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111825108 · Cited by 210
Self-citationThe Role of Iron in the Immune Response to Bacterial Infection
Cherayil, B. J. (2011) · Immunologic Research · doi:10.1007/s12026-010-8199-1 · Cited by 191
Blomgran, R., Desvignes, L., Briken, V., & Ernst, J. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2011.11.012 · Cited by 202
Vitamin D and the Skin: An Update for Dermatologists
Kechichian, E. G., & Ezzedine, K. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0323-8 · Cited by 195
Gong, W., & Wu, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.745592 · Cited by 176
Dorhoi, A., Reece, S. T., & Kaufmann, S. H. E. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00994.x · Cited by 172
Beyond macrophages: the diversity of mononuclear cells in tuberculosis
Srivastava, S., Ernst, J., & Desvignes, L. (2014) · Immunological Reviews · doi:10.1111/imr.12217 · Cited by 174
Ezenwa, V. O., & Jolles, A. E. (2015) · Science · doi:10.1126/science.1261714 · Cited by 167
Host-Directed Therapeutic Strategies for Tuberculosis
Kolloli, A., & Subbian, S. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00171 · Cited by 164
Early clearance of M ycobacterium tuberculosis : a new frontier in prevention
Verrall, A. J., Netea, M. G., Alisjahbana, B., Hill, P. C., & van Crevel, R. (2013) · Immunology · doi:10.1111/imm.12223 · Cited by 162
Human Immunology of Tuberculosis
Scriba, T. J., Coussens, A. K., & Fletcher, H. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0016-2016 · Cited by 158
Coussens, A. K., Timms, P. M., Boucher, B. J., Venton, T. R., Ashcroft, A., Skolimowska, K. H., Newton, S. M., Wilkinson, K. A., Davidson, R. N., Griffiths, C., et al. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.03024.x · Cited by 152
Self-citationHost-Directed Therapeutics for Tuberculosis: Can We Harness the Host?
Hawn, T. R., Matheson, A. I., Maley, S. N., & Vandal, O. H. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00032-13 · Cited by 152
Cadena, A. M., Flynn, J. L., & Fortune, S. M. (2016) · mBio · doi:10.1128/mbio.00342-16 · Cited by 153
Corleis, B., Korbel, D., Wilson, R., Bylund, J., Chee, R., & Schaible, U. E. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01783.x · Cited by 150
Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis
Dorhoi, A., & Kaufmann, S. H. E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0531-3 · Cited by 155
Lipocalin 2-Dependent Inhibition of Mycobacterial Growth in Alveolar Epithelium
Saiga, H., Nishimura, J., Kuwata, H., Okuyama, M., Matsumoto, S., Sato, S., Matsumoto, M., Akira, S., Yoshikai, Y., Honda, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8521 · Cited by 133
Neutrophilia independently predicts death in tuberculosis
Lowe, D. M., Bandara, A. K., Packe, G. E., Barker, R. D., Wilkinson, R. J., Griffiths, C., & Martineau, A. R. (2013) · European Respiratory Journal · doi:10.1183/09031936.00140913 · Cited by 128
Self-citationThe human cathelicidin hCAP18/LL-37: A multifunctional peptide involved in mycobacterial infections
Méndez‐Samperio, P. (2010) · Peptides · doi:10.1016/j.peptides.2010.06.016 · Cited by 128
The Immune Response toMycobacterium tuberculosisin HIV-1-Coinfected Persons
Esmail, H., Riou, C., Bruyn, E. D., Lai, R., Harley, Y. X. R., Meintjes, G., Wilkinson, K. A., & Wilkinson, R. J. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053420 · Cited by 117
Self-citationAntimicrobial peptides and proteins in mycobacterial therapy: Current status and future prospects
Padhi, A., Sengupta, M., Sengupta, S., Roehm, K. H., & Sonawane, A. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.03.011 · Cited by 127
Host-Directed Therapies for Tuberculosis: Figure 1.Preprint
Tobin, D. M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021196 · Cited by 123
Sia, J. K., Georgieva, M., & Rengarajan, J. (2015) · Journal of Immunology Research · doi:10.1155/2015/747543 · Cited by 140
Association between Gc genotype and susceptibility to TB is dependent on vitamin D status
Martineau, A. R., Leandro, A. C., Anderson, S. T. B., Newton, S. M., Wilkinson, K. A., Nicol, M. P., Pienaar, S., Skolimowska, K. H., Rocha, M. A. D., Rolla, V. C., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00087009 · Cited by 123
Self-citationLipocalin 2 in cancer: When good immunity goes bad
Rodvold, J. J., Mahadevan, N. R., & Zanetti, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.002 · Cited by 124
Allie, N., Grivennikov, S. I., Keeton, R. S., Hsu, N., Bourigault, M.-L., Court, N., Fremond, C., Yeremeev, V., Shebzukhov, Y. V., Ryffel, B., et al. (2013) · Scientific Reports · doi:10.1038/srep01809 · Cited by 122
Innate Immune Responses to Tuberculosis
Schorey, J. S., & Schlesinger, L. S. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0010-2016 · Cited by 125
Kozakiewicz, L., Chen, Y., Xu, J., Wang, Y., Dunussi‐Joannopoulos, K., Ou, Q., Flynn, J. L., Porcelli, S. A., Jacobs, W. R., & Chan, J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003472 · Cited by 123
Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis
Dawson, R., Condos, R., Tse, D. B., Huie, M. L., Ress, S., Tseng, C., Brauns, C., Weiden, M. D., Hoshino, Y., Bateman, E. D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006984 · Cited by 121
Host defense mechanisms against Mycobacterium tuberculosis
Chai, Q., Lü, Z., & Liu, C. H. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03353-5 · Cited by 125
Gideon, H. P., Phuah, J. Y., Junecko, B. A. F., & Mattila, J. T. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0195-8 · Cited by 106
Tsiganov, E. N., Verbina, E. M., Radaeva, T. V., Sosunov, V. V., Kosmiadi, G. A., Nikitina, I., & Lyadova, I. V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301365 · Cited by 112
Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology
Hahn, S., Giaglis, S., Chowdhury, C. S., Hösli, I., & Hasler, P. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0380-x · Cited by 111
Role of iron in the pathogenesis of respiratory disease
Ali, M. K., Kim, R., Karim, R., Mayall, J., Martin, K. L., Shahandeh, A., Abbasian, F., Starkey, M. R., Loustaud-Ratti, V., Johnstone, D. M., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.05.003 · Cited by 114
Neutrophils in Tuberculosis: Heterogeneity Shapes the Way?
Lyadova, I. V. (2017) · Mediators of Inflammation · doi:10.1155/2017/8619307 · Cited by 110
The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease
Abhimanyu, A., & Coussens, A. K. (2017) · Photochemical & Photobiological Sciences · doi:10.1039/c6pp00355a · Cited by 106
Stek, C. J., Allwood, B., Walker, N. F., Wilkinson, R. J., Lynen, L., & Meintjes, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02603 · Cited by 105
Self-citationOld wine in new bottles: vitamin D in the treatment and prevention of tuberculosis
Martineau, A. R. (2011) · Proceedings of The Nutrition Society · doi:10.1017/s0029665111003326 · Cited by 98
Self-citationInnate immunity to mycobacteria: vitamin D and autophagy
Jo, E.-K. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01491.x · Cited by 98
Human Lung Immunity against Mycobacterium tuberculosis : Insights into Pathogenesis and Protection
Schwander, S., & Dheda, K. U. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0963pp · Cited by 96
HIV-1 and the Immune Response to TB
Walker, N. F., Meintjes, G., & Wilkinson, R. J. (2012) · Future Virology · doi:10.2217/fvl.12.123 · Cited by 101
Self-citationO’Kane, C. M., McKeown, S., Perkins, G. D., Bassford, C. R., Gao, F., THICKETT, D. R., & McAuley, D. F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a5506c · Cited by 92
Trained innate immunity and resistance to Mycobacterium tuberculosis infection
Koeken, V. A. C. M., Verrall, A. J., Netea, M. G., Hill, P. C., & van Crevel, R. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.02.015 · Cited by 91
Morel, C., Badell, E., Abadie, V., Robledo-Sarmiento, M., Setterblad, N., Gluckman, J. C., Gicquel, B., Boudaly, S., & Winter, N. (2008) · European Journal of Immunology · doi:10.1002/eji.200737905 · Cited by 95
Role of neutrophils in tuberculosis: A bird's eye view
Hilda, J. N., Das, S. D., Tripathy, S. P., & Hanna, L. E. (2019) · Innate Immunity · doi:10.1177/1753425919881176 · Cited by 92
The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
Eribo, O. A., du Plessis, N., Ozturk, M., Guler, R., Walzl, G., & Chegou, N. N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03370-4 · Cited by 93
Immune correlates of tuberculosis disease and risk translate across species
Ahmed, M., Thirunavukkarasu, S., Rosa, B. A., Thomas, K. A., Das, S., Rangel-Moreno, J., Lu, L., Mehra, S., Mbandi, S. K., Thackray, L. B., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0233 · Cited by 89
Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis
Gupta, M., Srikrishna, G., Klein, S. L., & Bishai, W. R. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.06.004 · Cited by 91
D’Ávila, H., Roque, N. R., Cardoso, R. M., Castro-Faria-Neto, H. C., Melo, R. C. N., & Bozza, P. T. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01233.x · Cited by 87
SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis
Rottenberg, M. E., & Carow, B. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.10.004 · Cited by 84
Uciechowski, P., Imhoff, H., Lange, C. G., Meyer, C. G., Browne, E. N. L., Kirsten, D. K., Schröder, A., Schaaf, B., Al‐Lahham, A., Reinert, R. R., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0409233 · Cited by 83
Panteleev, A. V., Nikitina, I., Burmistrova, I. A., Kosmiadi, G. A., Radaeva, T. V., Amansahedov, R. B., Садиков, П. В., Serdyuk, Y. V., Ларионова, Е. Е., Bagdasarian, T. R., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00963 · Cited by 82
Antimicrobial peptides as an alternative to anti-tuberculosis drugs
AlMatar, M., Makky, E. A., Yakıcı, G., Var, İ., Kayar, B., & Köksal, F. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.10.011 · Cited by 81
Green, J. A., Tran, C. T. H., Farrar, J., Nguyen, M. T. H., Nguyen, P. H., Sinh, D. X., Trung, N. H. D., Ly, C. V., Tran, H. T., Friedland, J. S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007277 · Cited by 79
Freches, D., Korf, H., Denis, O., Havaux, X., Huygen, K., & Romano, M. (2013) · Immunology · doi:10.1111/imm.12130 · Cited by 78
Cowan, J., Pandey, S., Filion, L. G., Angel, J. B., Kumar, A., & Cameron, D. W. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04520.x · Cited by 81
Immune Vulnerability of Infants to Tuberculosis
Driessche, K. V., Persson, A., Marais, B. J., Fink, P. J., & Urdahl, K. B. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/781320 · Cited by 83
Induction of β-defensins by l -isoleucine as novel immunotherapy in experimental murine tuberculosis
Rivas-Santiago, C., Rivas-Santiago, B. T., Aguilar‐León, D., Castañeda‐Delgado, J. E., & Hernández‐Pando, R. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04313.x · Cited by 77
Gonzalez-Curiel, I. E., Castañeda‐Delgado, J. E., López‐López, N., Araujo, Z., Hernández‐Pando, R., Gándara-Jasso, B., Macías-Segura, N., Enciso‐Moreno, J. A., & Rivas-Santiago, B. T. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.03.027 · Cited by 76
Lipocalin 2 regulation and its complex role in inflammation and cancer
Li, C., & Chan, Y. R. (2011) · Cytokine · doi:10.1016/j.cyto.2011.07.021 · Cited by 79
Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis
Arranz‐Trullén, J., Lu, L., Pulido, D., Bhakta, S., & Boix, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01499 · Cited by 77
Mycobacterium tuberculosis biology, pathogenicity and interaction with the host
Warner, D. F., Barczak, A. K., Gutierrez, M. G., & Mizrahi, V. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01201-x · Cited by 81
Neutrophil counts in persons of African origin
Thobakgale, C., & Ndung’u, T. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000007 · Cited by 76
Pulido, D., Torrent, M., Andreu, D., Nogués, M. V., & Boix, E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00428-13 · Cited by 75
Sutherland, J. S., Jeffries, D. J., Donkor, S. A., Walther, B., Hill, P. C., Adetifa, I., Adegbola, R. A., & Ota, M. O. C. (2009) · Tuberculosis · doi:10.1016/j.tube.2009.07.004 · Cited by 74
Development of Vaccines Against Burkholderia Pseudomallei
Patel, N., Conejero, L., de Reynal, M., Easton, A., Bancroft, G. J., & Titball, R. W. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00198 · Cited by 73
Immunological consequences of strain variation within the Mycobacterium tuberculosis complex
Tientcheu, L. D., Koch, A. S., Ndengane, M., Andoseh, G., Kampmann, B., & Wilkinson, R. J. (2017) · European Journal of Immunology · doi:10.1002/eji.201646562 · Cited by 70
Self-citationSutherland, J. S., Loxton, A. G., Haks, M. C., Kassa, D., Ambrose, L. R., Lee, J., Ran, L., van Baarle, D., Maertzdorf, J., Howe, R., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12383 · Cited by 73
Jena, P., Mohanty, S., Mohanty, T., Kallert, S., Mörgelin, M., Lindenstrøm, T., Borregaard, N., Stenger, S., Sonawane, A., & Sørensen, O. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050345 · Cited by 71
Greiller, C. L., Suri, R., Jolliffe, D. A., Kebadze, T., Hirsman, A. G., Griffiths, C., Johnston, S. L., & Martineau, A. R. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.11.013 · Cited by 71
Self-citationLipocalin 2 Regulates Inflammation during Pulmonary Mycobacterial Infections
Guglani, L., Gopal, R., Rangel-Moreno, J., Junecko, B. F., Lin, Y., Berger, T., Mak, T. W., Alcorn, J. F., Randall, T. D., Reinhart, T. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050052 · Cited by 68
“tuberculosis by Lcn2 [17,18,19], our data suggests that absence of Lcn2 does not impact overall control of bacteria in the lung or dissemination to other organs following low dose pulmonary M.”
BackgroundFoster, M., Hill, P. C., Setiabudiawan, T. P., Koeken, V. A. C. M., Alisjahbana, B., & van Crevel, R. (2021) · Immunological Reviews · doi:10.1111/imr.12965 · Cited by 74
Is Mycobacterium tuberculosis stressed out? A critical assessment of the genetic evidence
Stallings, C. L., & Glickman, M. S. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.07.014 · Cited by 73
Metadata
- Authors
- Martineau, A. R., Newton, S. M., Wilkinson, K. A., Kampmann, B., Hall, B. M., Nawroly, N., Packe, G. E., Davidson, R. N., Griffiths, C. J., & Wilkinson, R. J.
- Affiliations
- Imperial College London (GB)
- University of Cape Town (ZA)
- Queen Mary University of London (GB)
- Newham University Hospital (GB)
- Northwick Park Hospital (GB)
- Venue
- Journal of Clinical Investigation
- Published
- 2007-07-02
- Volume
- 117
- Issue
- 7
- Pages
- 1988-1994
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1904316
- OpenAlex
- W2014262351
- Cited by
- 394
- References
- 37
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 13 · 2023: 16 · 2022: 15 · 2021: 23 · 2020: 15 · 2019: 31 · 2018: 27 · 2017: 29 · 2016: 19 · 2015: 21 · 2014: 26 · 2013: 29 · 2012: 20
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (077273, 072070, 066321, 064261)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- neutrophils, tuberculosis, Mycobacterium tuberculosis, Mycobacterium bovis BCG, antimicrobial peptides, human neutrophil peptides, cathelicidin LL-37, neutrophil gelatinase-associated lipocalin, innate immunity, TB contacts, neutrophil depletion, ethnic differences
- MeSH terms
- Female, Humans, Immunity, Innate, Leukocyte Count, Male, Mycobacterium bovis, Mycobacterium tuberculosis, Neutrophils, Tuberculosis, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review